Literature DB >> 26584554

Paediatric clinically isolated syndromes: report of seven cases, differential diagnosis and literature review.

Chiara Trabatti1, Thomas Foiadelli2, Maria Valentina Spartà2, Chiara Gagliardone2, Berardo Rinaldi3, Maria Delmonte4, Alessandro Lozza5, Salvatore Savasta2.   

Abstract

PURPOSE: Few paediatric cases of clinically isolated syndrome (CIS) have been described in literature, even though it has been increasingly recognized also in this age group. Our study retrospectively enrolled seven Italian patients (four males and three females) who met the International Paediatric Multiple Sclerosis Study Group (IPMSSG) 2012 criteria for clinically isolated syndrome over the period 2010-2014; their clinical, laboratory and imaging findings were compared with current literature and with those seen in five patients (three males and two females) with acute disseminated encephalomyelitis, who were followed in our department over the same years (mean follow-up time 2.84 ± 1.8 years).
RESULTS: In our CIS sample, male sex was prevalent, 42.8 % of patients had a multifocal presentation, MRI lesions mostly appeared confluent and with poorly defined margins, and CSF oligoclonal bands (OCBs) were identified in 28.6 %. All acute disseminated encephalomyelitis (ADEM) patients had polyfocal presentation and encephalopathy; large MRI subcortical lesions and polyclonal IgG distribution were identified. During the subsequent follow-up assessments, MRI scan revealed new lesions in three CIS patients, while in ADEM children it appeared normal.
CONCLUSIONS: Paediatric CIS patients often show peculiar epidemiological, clinical and radiological features, which significantly differ from adult ones. The presence of encephalopathy and of extended MRI lesions leads to a diagnosis of ADEM, instead. In CIS patients the presence of multiple asymptomatic MRI lesions and of OCBs revealed to be the most predictive risk factors for progression to clinically definite multiple sclerosis (CDMS), so a regular long-term follow-up is recommended; in ADEM, no suitable risk factors for a relapse could be identified.

Entities:  

Keywords:  ADEM; CIS; Children; Clinically definite multiple sclerosis; Demyelinating diseases; Differential diagnosis

Mesh:

Year:  2015        PMID: 26584554     DOI: 10.1007/s00381-015-2959-0

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  49 in total

Review 1.  Corticosteroids and plasma exchange in multiple sclerosis.

Authors:  Hayretin Tumani
Journal:  J Neurol       Date:  2008-12       Impact factor: 4.849

Review 2.  Clinically isolated syndromes and the relationship to multiple sclerosis.

Authors:  Wallace J Brownlee; David H Miller
Journal:  J Clin Neurosci       Date:  2014-07-11       Impact factor: 1.961

Review 3.  The role of gender and sex hormones in determining the onset and outcome of multiple sclerosis.

Authors:  Riley Bove; Tanuja Chitnis
Journal:  Mult Scler       Date:  2014-02-21       Impact factor: 6.312

4.  Smoking and multiple sclerosis: evidence for latitudinal and temporal variation.

Authors:  C O'Gorman; S A Broadley
Journal:  J Neurol       Date:  2014-06-13       Impact factor: 4.849

5.  Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis.

Authors:  Jan D Lünemann; Mar Tintoré; Brady Messmer; Till Strowig; Alex Rovira; Héctor Perkal; Estrella Caballero; Christian Münz; Xavier Montalban; Manuel Comabella
Journal:  Ann Neurol       Date:  2010-02       Impact factor: 10.422

6.  Risk genes associated with pediatric-onset MS but not with monophasic acquired CNS demyelination.

Authors:  E Daniëlle van Pelt; Julia Y Mescheriakova; Nalia Makhani; Immy A Ketelslegers; Rinze F Neuteboom; Suman Kundu; Linda Broer; Cecile Janssens; Coriene E Catsman-Berrevoets; Cornelia M van Duijn; Brenda Banwell; Amit Bar-Or; Rogier Q Hintzen
Journal:  Neurology       Date:  2013-11-06       Impact factor: 9.910

Review 7.  Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.

Authors:  M Andersson; J Alvarez-Cermeño; G Bernardi; I Cogato; P Fredman; J Frederiksen; S Fredrikson; P Gallo; L M Grimaldi; M Grønning
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

8.  2010 McDonald criteria for diagnosing pediatric multiple sclerosis.

Authors:  Yair Sadaka; Leonard H Verhey; Manohar M Shroff; Helen M Branson; Douglas L Arnold; Sridar Narayanan; John G Sled; Amit Bar-Or; A Dessa Sadovnick; Melissa McGowan; Ruth Ann Marrie; Brenda Banwell
Journal:  Ann Neurol       Date:  2012-08       Impact factor: 10.422

9.  Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study.

Authors:  O Andersen; P E Lygner; T Bergström; M Andersson; A Vahlne
Journal:  J Neurol       Date:  1993-07       Impact factor: 4.849

Review 10.  Pediatric central nervous system inflammatory demyelination: acute disseminated encephalomyelitis, clinically isolated syndromes, neuromyelitis optica, and multiple sclerosis.

Authors:  Russell C Dale; Fabienne Brilot; Brenda Banwell
Journal:  Curr Opin Neurol       Date:  2009-06       Impact factor: 5.710

View more
  1 in total

Review 1.  Current Advances in Pediatric Onset Multiple Sclerosis.

Authors:  Kristen S Fisher; Fernando X Cuascut; Victor M Rivera; George J Hutton
Journal:  Biomedicines       Date:  2020-03-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.